88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

Real World ◽

Controlled Trial ◽

Similar Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Real World Setting ◽

Sodium Glucose Cotransporter

Digitally supported program for type 2 diabetes risk identification and risk reduction in real-world setting: protocol for the StopDia model and randomized controlled trial

BMC Public Health ◽

10.1186/s12889-019-6574-y ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 7

Author(s):

Jussi Pihlajamäki ◽

◽

Reija Männikkö ◽

Tanja Tilles-Tirkkonen ◽

Leila Karhunen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Risk Reduction ◽

Real World ◽

Controlled Trial ◽

Risk Identification ◽

Diabetes Risk ◽

Randomized Controlled ◽

Real World Setting

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Metabolic Syndrome and Obesity Targets and Therapy ◽

10.2147/dmso.s219496 ◽

2020 ◽

Vol Volume 13 ◽

pp. 423-431 ◽

Cited By ~ 1

Author(s):

Nuntakorn Thongtang ◽

Jirasak Piyapromdee ◽

Natthakan Tangkittikasem ◽

Kittichai Samaithongcharoen ◽

Nithiwat Srikanchanawat ◽

...

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

High Intensity ◽

Low Dose ◽

Controlled Trial ◽

Efficacy And Safety ◽

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Diabetes Care ◽

10.2337/dc13-2759 ◽

2014 ◽

Vol 37 (8) ◽

pp. 2168-2176 ◽

Cited By ~ 166

Author(s):

Guillermo Umpierrez ◽

Santiago Tofé Povedano ◽

Federico Pérez Manghi ◽

Linda Shurzinske ◽

Valeria Pechtner

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2011.07.035 ◽

2011 ◽

Vol 94 (2) ◽

pp. 217-224 ◽

Cited By ~ 73

Author(s):

Wenying Yang ◽

Chang Yu Pan ◽

Conrad Tou ◽

June Zhao ◽

Ingrid Gause-Nilsson

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Asian People

Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial

Diabetes & Metabolism Journal ◽

10.4093/dmj.2020.0274 ◽

2021 ◽

Author(s):

Jae Hyun Bae ◽

Chang Ho Ahn ◽

Ye Seul Yang ◽

Sun Joon Moon ◽

Soo Heon Kwak ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Titration Study

Comparison of Efficacy and Safety of Hydroxychloroquine and Teneligliptin in Type 2 Diabetes Patients who are Inadequately Controlled with Glimepiride, Metformin and Insulin therapy: A Randomized Controlled Trial with Parallel Group Design

10.29328/journal.acem.1001009 ◽

2017 ◽

Vol 2 (1) ◽

pp. 033-040 ◽

Cited By ~ 2

Author(s):

Ahsan Sajjad

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Group Design ◽

Randomized Controlled ◽

Parallel Group Design ◽

Parallel Group

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc19-1745 ◽

2020 ◽

Vol 43 (5) ◽

pp. 1085-1093 ◽

Cited By ~ 7

Author(s):

W. Timothy Garvey ◽

Andreas L. Birkenfeld ◽

Dror Dicker ◽

Geltrude Mingrone ◽

Sue D. Pedersen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Overweight Or Obesity

Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672–1680

Diabetes Care ◽

10.2337/dc19-er08 ◽

2019 ◽

Vol 42 (8) ◽

pp. 1604.1-1604

Author(s):

Robert Ritzel ◽

Stewart B. Harris ◽

Helen Baron ◽

Hermes Florez ◽

Ronan Roussel ◽

...

Keyword(s):

Type 2 Diabetes ◽

Older People ◽

Insulin Glargine ◽

Diabetes Care ◽

Controlled Trial ◽

Efficacy And Safety ◽

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)

Diabetes Care ◽

10.2337/dc13-2761 ◽

2014 ◽

Vol 37 (8) ◽

pp. 2149-2158 ◽

Cited By ~ 163

Author(s):

Michael Nauck ◽

Ruth S. Weinstock ◽

Guillermo E. Umpierrez ◽

Bruno Guerci ◽

Zachary Skrivanek ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽